Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

Product portfolio
Potentially strong market reviews
Competitive analytics
Prospect partners
Mergers and acquisitions project data
Latest trends across a particular industry area
Research and development strategies
The analysis of new customers
A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 5,853

Sort by:

Arachidonate 5 Lipoxygenase Activating Protein (MK 886 Binding Protein or FLAP or ALOX5AP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Arachidonate 5 Lipoxygenase Activating Protein (MK 886 Binding Protein or FLAP or ALOX5AP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMAR...

May 2022 35 pages

Arenaviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Arenaviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Arenaviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 61 pages

Arginase 1 (Liver Type Arginase or Type I Arginase or ARG1 or EC 3.5.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Arginase 1 (Liver Type Arginase or Type I Arginase or ARG1 or EC 3.5.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Arginase 1 (Liv...

May 2022 35 pages

Aromatase (Estrogen Synthase or Cytochrome P 450AROM or Cytochrome P450 19A1 or CYP19A1 or EC 1.14.14.14) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Aromatase (Estrogen Synthase or Cytochrome P 450AROM or Cytochrome P450 19A1 or CYP19A1 or EC 1.14.14.14) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 37 pages

Aromatic L Amino Acid Decarboxylase (AADC or Dopa Decarboxylase or DDC or EC 4.1.1.28) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Aromatic L Amino Acid Decarboxylase (AADC or Dopa Decarboxylase or DDC or EC 4.1.1.28) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Ar...

May 2022 51 pages

Arteriosclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Arteriosclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Arteriosclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 138 pages

Articular Cartilage Defect Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Articular Cartilage Defect Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Articular Cartilage Defect Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 36 pages

Arylsulfatase A (Cerebroside Sulfatase or ASA or ARSA or EC 3.1.6.8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Arylsulfatase A (Cerebroside Sulfatase or ASA or ARSA or EC 3.1.6.8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Arylsulfatase A (Cer...

May 2022 39 pages

Ascites Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Ascites Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ascites Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an over...

May 2022 38 pages

Aspartoacylase (Aminoacylase 2 or ACY2 or ASPA or EC 3.5.1.15) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Aspartoacylase (Aminoacylase 2 or ACY2 or ASPA or EC 3.5.1.15) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Aspartoacylase (Aminoacyla...

May 2022 40 pages

Ataxin 3 (Machado Joseph Disease Protein 1 or Spinocerebellar Ataxia Type 3 Protein or SCA3 or ATXN3 or EC 3.4.19.12) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Ataxin 3 (Machado Joseph Disease Protein 1 or Spinocerebellar Ataxia Type 3 Protein or SCA3 or ATXN3 or EC 3.4.19.12) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule...

May 2022 38 pages

Atopic Keratoconjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Atopic Keratoconjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Atopic Keratoconjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 35 pages

ATP Dependent Clp Protease Proteolytic Subunit Mitochondrial (Endopeptidase Clp or CLPP or EC 3.4.21.92) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

ATP Dependent Clp Protease Proteolytic Subunit Mitochondrial (Endopeptidase Clp or CLPP or EC 3.4.21.92) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 38 pages

Atrophic Vaginitis (Vaginal Atrophy-Vulvovaginal Atrophy-Urogenital Atrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Atrophic Vaginitis (Vaginal Atrophy-Vulvovaginal Atrophy-Urogenital Atrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Atrophic Vaginitis (Vaginal Atrophy...

May 2022 38 pages

Auto Inflammatory Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Auto Inflammatory Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Auto Inflammatory Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 39 pages

Autoimmune Hepatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Autoimmune Hepatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Autoimmune Hepatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 44 pages

Avian Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Avian Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Avian Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 105 pages

B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY B-Cell Acute Lymphocytic Leukemia (B-Ce...

May 2022 191 pages

B-Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

B-Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY B-Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 135 pages

B Cell Lymphoma 2 (Bcl 2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

B Cell Lymphoma 2 (Bcl 2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY B Cell Lymphoma 2 (Bcl 2) Drugs in Development by Therapy Areas...

May 2022 99 pages

B Cell Lymphoma-Leukemia 11A (B Cell CLL-Lymphoma 11A or COUP TF Interacting Protein 1 or Ecotropic Viral Integration Site 9 Protein Homolog or Zinc Finger Protein 856 or BCL11A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

B Cell Lymphoma-Leukemia 11A (B Cell CLL-Lymphoma 11A or COUP TF Interacting Protein 1 or Ecotropic Viral Integration Site 9 Protein Homolog or Zinc Finger Protein 856 or BCL11A) Drugs in Development...

May 2022 36 pages

B Lymphocyte Antigen CD19 (B Lymphocyte Surface Antigen B4 or Differentiation Antigen CD19 or T Cell Surface Antigen Leu 12 or CD19) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

B Lymphocyte Antigen CD19 (B Lymphocyte Surface Antigen B4 or Differentiation Antigen CD19 or T Cell Surface Antigen Leu 12 or CD19) Drugs in Development by Therapy Areas and Indications, Stages, MoA,...

May 2022 38 pages

B2 Bradykinin Receptor (BK2 Receptor or BDKRB2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

B2 Bradykinin Receptor (BK2 Receptor or BDKRB2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY B2 Bradykinin Receptor (BK2 Receptor or B...

May 2022 35 pages

Bacillary Dysentery (Shigellosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bacillary Dysentery (Shigellosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bacillary Dysentery (Shigellosis) Drugs in Development by Stages, Target, MoA,...

May 2022 54 pages

Bacillus Anthracis Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bacillus Anthracis Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bacillus Anthracis Infections Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 71 pages

Back Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Back Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Back Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...

May 2022 84 pages

Bacteremia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Bacteremia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bacteremia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...

May 2022 213 pages

Bacterial Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bacterial Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bacterial Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 37 pages

Bacterial Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Bacterial Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bacterial Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 134 pages

Bacterial Sepsis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bacterial Sepsis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bacterial Sepsis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 44 pages

Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and...

May 2022 52 pages

Barth Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Barth Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Barth Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 36 pages

Bcr-Abl Tyrosine Kinase (EC 2.7.10.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Bcr-Abl Tyrosine Kinase (EC 2.7.10.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Bcr-Abl Tyrosine Kinase (EC 2.7.10.2) Drugs in Deve...

May 2022 61 pages

Benign Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Benign Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Benign Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 81 pages

Beta 1 Adrenergic Receptor (Beta 1 Adrenoreceptor or ADRB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Beta 1 Adrenergic Receptor (Beta 1 Adrenoreceptor or ADRB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Beta 1 Adrenergic Receptor (B...

May 2022 70 pages

Beta 2 Adrenergic Receptor (Beta 2 Adrenoreceptor or ADRB2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Beta 2 Adrenergic Receptor (Beta 2 Adrenoreceptor or ADRB2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Beta 2 Adrenergic Receptor (B...

May 2022 97 pages

Beta 3 Adrenergic Receptor (Beta 3 Adrenoreceptor or ADRB3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Beta 3 Adrenergic Receptor (Beta 3 Adrenoreceptor or ADRB3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Beta 3 Adrenergic Receptor (B...

May 2022 41 pages

Beta Adrenergic Receptor (ADRB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Beta Adrenergic Receptor (ADRB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Beta Adrenergic Receptor (ADRB) Drugs in Development by T...

May 2022 131 pages

Beta Galactosidase (Acid Beta Galactosidase or Lactase or Elastin Receptor 1 or GLB1 or EC 3.2.1.23) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Beta Galactosidase (Acid Beta Galactosidase or Lactase or Elastin Receptor 1 or GLB1 or EC 3.2.1.23) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Play...

May 2022 41 pages

Beta Glucuronidase (Beta G1 or Beta D Glucuronidase or GUSB or EC 3.2.1.31) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Beta Glucuronidase (Beta G1 or Beta D Glucuronidase or GUSB or EC 3.2.1.31) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Beta Glucuron...

May 2022 36 pages

Beta Tubulin (TUBB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Beta Tubulin (TUBB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Beta Tubulin (TUBB) Drugs in Development by Therapy Areas and Indicat...

May 2022 38 pages

Biliary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Biliary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Biliary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 52 pages

Bipolar Disorder (Manic Depression) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bipolar Disorder (Manic Depression) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bipolar Disorder (Manic Depression) Drugs in Development by Stages, Target,...

May 2022 75 pages

Bleeding And Clotting Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Bleeding And Clotting Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bleeding And Clotting Disorders Drugs in Development by Stages, Target, MoA, RoA...

May 2022 266 pages

Blepharospasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Blepharospasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Blepharospasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 36 pages

Blood Coagulation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Blood Coagulation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Blood Coagulation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 45 pages

Bone Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Bone Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bone Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 263 pages

Bone Fracture Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bone Fracture Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bone Fracture Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 61 pages

Bone Regeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Bone Regeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bone Regeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 43 pages

Bone Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Bone Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Bone Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 236 pages